A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients

Clinical trial NCT00734032 · COMPLETED

Trial details

NCT number: NCT00734032
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-08-26
Primary completion: 2009-01-16
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.